Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $29.6600 (-1.72%) ($29.5000 - $30.6900) on Wed. Jun. 17, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.63% (three month average) | RSI | 35 | Latest Price | $29.6600(-1.72%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -1.2% a day on average for past five trading days. | Weekly Trend | IOVA declines -4.6% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(48%) XBI(46%) ARKG(44%) IWO(42%) ARKK(40%) | Factors Impacting IOVA price | IOVA will decline at least -3.315% in a week (0% probabilities). VIXM(-23%) UUP(-17%) VXX(-13%) TBT(-5%) UNG(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.315% (StdDev 6.63%) | Hourly BBV | 0 () | Intraday Trend | -2.4% | | | |
|
1 - 5 Day Possible Target | $12.3(-58.53%) | Resistance Level | $32.93 | 5 Day Moving Average | $29.78(-0.4%) | 10 Day Moving Average | $30.65(-3.23%) | 20 Day Moving Average | $32.93(-9.93%) | To recent high | -27.7% | To recent low | 48.4% | Market Cap | $4.343b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |